InvestorsHub Logo

Webconcepts

01/25/13 9:15 PM

#67662 RE: Penny Monster 01 #67661

Burmamonster

01/25/13 9:41 PM

#67664 RE: Penny Monster 01 #67661

http://www.gwpharm.com/types-compounds.aspx

GW is developing a portfolio of cannabinoid medicines, of which the lead product is Sativex, an oromucosal spray for the treatment of MS symptoms, cancer pain and neuropathic pain.